Entering text into the input field will update the search result below

Abbott baby formula plant resumes operations after flooding

Jul. 09, 2022 9:11 PM ETAbbott Laboratories (ABT)By: Dulan Lokuwithana, SA News Editor8 Comments

Abbott Laboratories headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

  • Abbott Laboratories (NYSE:ABT) has reopened its baby formula plant in Sturgis, Michigan, after flooding in the area forced the company to shut its operations last month, a company spokesperson said Saturday.
  • Abbott (

Recommended For You

Comments (8)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Please remove the toxic seed oils from baby formulas!
The baby formula business is low margin because the government buys over half of the supply at very competitive prices. At the state level, one maker wins all the state supply contract for the child support program, leaving the other makers competing on the remaining free market.
I've got a significant position in ABT. My opinion is this is a great company and the baby formula debacle is noise. Take a look at their broad portfolio. Impressive,
@DavidHHolmes ABT would benefit from pulling out of the formula market as they don't make enough revenue from it for them to keep taking on massive FDA probes
Victor Justice profile picture
Unfortunately, the Biden administration and republican neocons are more concerned with getting weapons to Ukrainian neonazis’ than caring about American babies.

Breastfeeding should always be the first option when available. GOD’s plan for families are true and righteous altogether.
@Victor Justice I don’t recall any Bible verses about breastfeeding vs formula?
@Victor Justice Just go back to your church, and preach there. This is an investment website.

About ABT

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Abbott Laboratories
Stryker Corporation
Intuitive Surgical, Inc.
Medtronic plc
Boston Scientific Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.